Obese men with type IIB hyperlipidemia are insulin resistant

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 13, Issue 10, 1993, Pages 1469-1475

  Karhapää, Pauli ^a   Voutilainen, Erkki ^a   Malkki, Mari ^a   Laakso, Markku ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Insulin; Insulin resistance; Type IIB hyperlipidemia

Indexed keywords

CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; OBESITY; PRIORITY JOURNAL;

BLOOD GLUCOSE; CALORIMETRY, INDIRECT; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERLIPIDEMIA; INSULIN; INSULIN RESISTANCE; LACTATES; LACTIC ACID; MALE; MIDDLE AGE; OBESITY; SUPPORT, NON-U.S. GOV'T;

EID: 0027428323     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.13.10.1469     Document Type: Article

References (21)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-1568.
2. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia. Arteriosclerosis. 1987;7:203-207.
3. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res. 1983;24:147-155.
4. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO. Composition and distribution of LDL fractions in hypoapobetalipoproteinemia, normolipidemia and FH. Proc Natl Acad Sci USA. 1983;80:6662-6666.
5. Goldstein JL, Hazzard WR, Schrott WR, Bierman EL, Motulsky AG, Levinski MJ, Campell ED. Hyperlipidemia in coronary heart disease, I: lipid levels of 500 survivors of myocardial infarction. J Clin Invest. 1973;52:1534-1543.
6. Nikkilä EA, Aro A. Family study of lipids and lipoproteins in coronary heart disease. Lancet. 1973;1:954-958.
7. Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PWF, Salem DN, Schaefer J. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85:2025-2033.
8. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism. 1976;25:313-320.
9. Sniderman AD, Wolfson C, Teng B, Franklin F, Bachorik PS, Kwiterovich PO Jr. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med. 1982;97:833-839.
10. Kukita H, Hamada M, Hiwada K, Kokubu T. Clinical significance of measurement of serum apolipoproteins AI, All and B in hypertriglyceridemic male patients with and without coronary artery disease. Atherosclerosis. 1985;55:143-149.
11. Durrington PN, Hunt I, Ishola M, Kane J, Stephens WP. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J. 1986;56:206-212.
12. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR. High prevalence of hypertriglyceridemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J. 1988;60:397-403.
13. Abbott WGH, Lillioja S, Young AA, Zawadzki JK, Yki-Järvinen H, Christin L, Howard BV. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes. 1987;36:897-904.
14. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 1990;10:223-231.
15. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism. 1988;37:982-987.
16. Karhapää P, Voutilainen E, Kovanen PT, Laakso M. Insulin resistance in familial and nonfamilial hypercholesterolemia. Arterioscler Thromb. 1993;13:41-47.
17. Olefsky JM, Farquhar JW, Reaven GM. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med. 1974;57:551-560.
18. Steiner G, Soichro M, Vranic M. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes. 1980;29:899-905.
19. McKane WR, Stevens AB, Woods R, Andrews WJ, Henry RW, Bell PM. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism. 1990;39:1240-1245.
20. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel J-M, Williams RR. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia: study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989;9:335-344.
21. Sarlund H, Pyörälä K, Penttilä I, Laakso M. Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12:657-663.